|
Volumn 20, Issue 4, 2005, Pages 177-182
|
Combination drug therapy in the management of pulmonary arterial hypertension.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTIHYPERTENSIVE AGENT;
ANTITHROMBOCYTIC AGENT;
BOSENTAN;
CALCIUM CHANNEL BLOCKING AGENT;
CARDIOTONIC AGENT;
DIURETIC AGENT;
ILOPROST;
PIPERAZINE DERIVATIVE;
PROSTACYCLIN;
PROSTAGLANDIN;
SILDENAFIL;
SULFONAMIDE;
VASODILATOR AGENT;
CLASSIFICATION;
DRUG COMBINATION;
DRUG MONITORING;
HOSPITALIZATION;
HUMAN;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PULMONARY HYPERTENSION;
REVIEW;
TREATMENT OUTCOME;
ANTICOAGULANTS;
ANTIHYPERTENSIVE AGENTS;
CALCIUM CHANNEL BLOCKERS;
CARDIOTONIC AGENTS;
DIURETICS;
DRUG MONITORING;
DRUG THERAPY, COMBINATION;
EPOPROSTENOL;
HUMANS;
HYPERTENSION, PULMONARY;
ILOPROST;
PIPERAZINES;
PLATELET AGGREGATION INHIBITORS;
PRACTICE GUIDELINES;
PROSTAGLANDINS;
SEVERITY OF ILLNESS INDEX;
SULFONAMIDES;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
|
EID: 33644877605
PISSN: 08897204
EISSN: None
Source Type: Journal
DOI: 10.1111/j.0889-7204.2005.04039.x Document Type: Review |
Times cited : (2)
|
References (29)
|